Veracuity blog

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email
Share on print

To increase the reach, Veracuity LLC and Alliance for Clinical Research Excellence and Safety (ACRES) now offer the survey in multiple languages, including Italian and Spanish. TransPerfect Life Sciences, a leading provider for global development and commercialization of drugs, treatments, and devices, has generously donated translation services in support of these efforts.

Healthcare providers or hospitals interested in completing the survey or contributing data to the initiative can do so at https://www.acresglobal.net/covid-19. The target audience for the survey is any healthcare team or professional caring for hospitalized COVID-19 patients.

The global nature of COVID-19 means that the localization of the survey will enable data collection from a broader group of patients, allowing for a better understanding of elements that include risk-factor identification, triage, treatment management, and outcome predictors to gain insight into the safety and efficacy of traditional, experimental, and off-label therapies.

More to explorer

Benchmarking AI in healthcare

Artificial intelligence (AI) models are becoming an indispensable part of healthcare delivery due to the ever-growing volumes of data the sector produces.

Subscribe to our newsletter